<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01465542</url>
  </required_header>
  <id_info>
    <org_study_id>APAP &amp; NAC 2008-2011</org_study_id>
    <nct_id>NCT01465542</nct_id>
  </id_info>
  <brief_title>Treatment of APAP Toxicity With IV and Oral NAC 2008-2011</brief_title>
  <official_title>Treatment of Acetaminophen Toxicity With Intravenous vs. Oral N-acetylcysteine: A Retrospective Review</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Akron Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Akron Children's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Retrospective chart review of patients who receive N-acetylcysteine for Acetaminophen(APAP)
      toxicity to assess length of oral vs. IV treatment and the effect of a Clinical Pharmacology
      and Toxicology division in the management of APAP ingestions.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2011</start_date>
  <completion_date type="Actual">November 2011</completion_date>
  <primary_completion_date type="Actual">August 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Length of NAC treatment in hours</measure>
    <time_frame>Retrospective data collection for patient's hospital admission, max estimated 5days</time_frame>
    <description>Length of NAC treatment (in hours) for both IV and PO formulations used in patients with APAP toxicity</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pharmacology &amp; Toxicology consults</measure>
    <time_frame>Retrospective data collection for length of patient's hospital admission, max estimated 5 days</time_frame>
    <description>Documenting whether or not a pharmacology &amp; toxicology consult was obtained during the patient's hospital admission for APAP toxicity</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">47</enrollment>
  <condition>Acetaminophen Toxicity</condition>
  <arm_group>
    <arm_group_label>Oral NAC</arm_group_label>
    <description>Patients receiving oral NAC treatment after an acute acetaminophen ingestion.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IV NAC</arm_group_label>
    <description>Patients receiving IV NAC after an acute Acetaminophen ingestion.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Pediatric and adolescent patients with acetaminophen toxicity.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Admitted to CHMCA between June 1, 2008 to June 30, 2011

          -  Qualifying ICD-9 diagnosis code for the following APAP overdose situations: poisoning,
             accidental, suicide attempt, therapeutic use, assualt, and undetermined(965.4, E850.4,
             E950.0, E935.4, E962.0, E980.0)

          -  Serum APAP concentration above the possible hepatotoxic line on the Rumack-Matthew's
             nomogram if obtained &gt; 4 hours post ingestion

          -  Between ages 0-21 years on date of admission

          -  Acute APAP ingestion

        Exclusion Criteria:

          -  Serum APAP concentrations not actually documented

          -  Did not receive the oral or IV NAC treatment

          -  Preexisting liver disease such as cirrhosis or hepatitis C

          -  Patient &gt; 21 years of age on the date of admission

          -  Chronic APAP ingestion
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martha Blackford, PharmD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHMCA</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Children's Hospital Medical Center of Akron</name>
      <address>
        <city>Akron</city>
        <state>Ohio</state>
        <zip>44308</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Dart RC, Erdman AR, Olson KR, Christianson G, Manoguerra AS, Chyka PA, Caravati EM, Wax PM, Keyes DC, Woolf AD, Scharman EJ, Booze LL, Troutman WG; American Association of Poison Control Centers. Acetaminophen poisoning: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol (Phila). 2006;44(1):1-18.</citation>
    <PMID>16496488</PMID>
  </reference>
  <reference>
    <citation>Kanter MZ. Comparison of oral and i.v. acetylcysteine in the treatment of acetaminophen poisoning. Am J Health Syst Pharm. 2006 Oct 1;63(19):1821-7. Review.</citation>
    <PMID>16990628</PMID>
  </reference>
  <reference>
    <citation>Whyte IM, Francis B, Dawson AH. Safety and efficacy of intravenous N-acetylcysteine for acetaminophen overdose: analysis of the Hunter Area Toxicology Service (HATS) database. Curr Med Res Opin. 2007 Oct;23(10):2359-68.</citation>
    <PMID>17705945</PMID>
  </reference>
  <reference>
    <citation>Yarema MC, Johnson DW, Berlin RJ, Sivilotti ML, Nettel-Aguirre A, Brant RF, Spyker DA, Bailey B, Chalut D, Lee JS, Plint AC, Purssell RA, Rutledge T, Seviour CA, Stiell IG, Thompson M, Tyberg J, Dart RC, Rumack BH. Comparison of the 20-hour intravenous and 72-hour oral acetylcysteine protocols for the treatment of acute acetaminophen poisoning. Ann Emerg Med. 2009 Oct;54(4):606-14. doi: 10.1016/j.annemergmed.2009.05.010. Epub 2009 Jun 25.</citation>
    <PMID>19556028</PMID>
  </reference>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 31, 2011</study_first_submitted>
  <study_first_submitted_qc>November 2, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 4, 2011</study_first_posted>
  <last_update_submitted>September 7, 2017</last_update_submitted>
  <last_update_submitted_qc>September 7, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Akron Children's Hospital</investigator_affiliation>
    <investigator_full_name>Martha Blackford, PharmD</investigator_full_name>
    <investigator_title>PharmD</investigator_title>
  </responsible_party>
  <keyword>Acetaminophen Toxicity</keyword>
  <keyword>Acetaminophen Overdose</keyword>
  <keyword>N-acetylcysteine</keyword>
  <keyword>Liver Toxicity</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Acetylcysteine</mesh_term>
    <mesh_term>N-monoacetylcystine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

